No-deal Brexit presents risk for EU patients as well as UK, manufacturers' representatives say
Proposals for a no-deal Brexit put forward by the Medicines and Healthcare products Regulatory Agency would put patients in the EU at risk, the Association of the British Pharmaceutical Industry and the UK Bioindustry Association have said.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | UK Health